Branchio-Oculo-Facial Syndrome (BOFS)

Branchio-oculo-facial syndrome (BOFS) is a rare condition that starts before birth. It affects the face, neck, eyes, and nearby skin. Many babies have thin or red skin patches on the neck or around the ears. The eyes may be small or have a gap in a structure called the “coloboma.” The face may have a cleft lip or a “pseudocleft” (a deep groove that looks like a repaired cleft). Ears, teeth, and the nose may look different. Some children have hearing loss or blocked tear ducts. Some people also have kidney problems. BOFS is usually caused by a change (mutation) in a single gene called TFAP2A. It is most often inherited in an autosomal dominant way, which means one changed copy of the gene can cause the condition. NCBI+2MedlinePlus+2

BOFS is a congenital syndrome that typically presents at birth with: (1) branchial skin defects on the side of the neck or near the ears, sometimes moist or “weeping”; (2) eye anomalies (e.g., microphthalmia, anophthalmia, coloboma, cataract, blocked tear ducts); and (3) distinctive facial features, which may include cleft lip/palate or a lip that looks like it was repaired (“pseudocleft”). It follows autosomal-dominant inheritance, most often due to TFAP2A variants, and care involves genetics, ENT, ophthalmology, craniofacial/dental, audiology, nephrology/urology, and rehabilitation. NCBI+2MedlinePlus+2

• “Branchio” refers to the branchial (pharyngeal) arches in an embryo. These arches form parts of the face and neck.

• “Oculo” means eye.

• “Facial” means face.
  So BOFS is a syndrome with branchial-area skin changes, eye changes, and facial differences. NCBI

Very rare. Fewer than 100 patients had been reported in early reviews, but more have been recognized since then. The exact number is still small worldwide. National Organization for Rare Disorders Harmful variants in the TFAP2A gene, which makes a protein called AP-2α. This protein helps control other genes during early development, especially in the face, neck, and eyes. When TFAP2A does not work correctly, normal development is disturbed. MedlinePlus

Other names

• BOFS (short form)

• Branchiooculofacial syndrome (spelled without hyphens)

• Hemangiomatous branchial clefts–lip pseudocleft syndrome (older name used in some sources) Wikipedia

Types

Experts usually describe one genetic condition (TFAP2A-related BOFS), but people can look very different. To make it easy to understand, here are clinical patterns that doctors often see. These are not strict subtypes, but they help describe how a person may present.

1. Classic BOFS pattern
   Skin patches near the ears or neck, eye anomalies (like coloboma or small eyes), and facial differences such as cleft lip/pseudocleft and broad nasal tip. This is the most typical picture. NCBI

2. Ocular-predominant pattern
   Some people mainly have eye problems (for example, coloboma or cataracts) and only mild or absent branchial/face signs. This has been reported in TFAP2A families. Frontiers

3. BOFS with significant hearing or ear anomalies
   External and middle ear changes can lead to conductive hearing loss; less often, there is sensorineural loss. NCBI

4. BOFS with kidney (renal) anomalies
   A notable minority have kidney malformations or kidney dysfunction, so screening is advised. Nature

5. BOFS with airway or feeding issues
   Because of clefting or facial structure, babies may have feeding problems or airway concerns that need team care. (This is well recognized in craniofacial syndromes such as BOFS.) NCBI

Causes

In BOFS, the root cause is a change in TFAP2A. Below are specific, evidence-based “causal mechanisms” and pathways by which BOFS can occur or vary. Together, they cover how the gene can be altered, how it is inherited, and why the features can differ from person to person.

1. Missense variants in TFAP2A
   A change in one “letter” of the gene alters a single amino acid in AP-2α, often in the DNA-binding region, so it cannot control other genes well. MedlinePlus

2. Nonsense or frameshift variants
   These produce a shortened or abnormal protein that does not work, leading to haploinsufficiency (not enough working protein). OUP Academic

3. Dominant-negative effects
   Some altered proteins can interfere with the normal protein from the healthy gene copy, making the effect stronger. OUP Academic

4. Regulatory (promoter/enhancer) variants
   Changes outside the coding region can reduce how much TFAP2A is made at key times in development. (Shown in molecular studies and reviews of variant classes.) OUP Academic

5. Whole-gene or partial gene deletions
   A larger missing piece that removes all or part of TFAP2A causes a loss of function. NCBI

6. Chromosomal rearrangements hitting TFAP2A
   Balanced or unbalanced changes can disrupt the gene or its control regions and lead to BOFS features. NCBI

7. De novo variants
   The change is new in the child and not seen in either parent; this is common in rare dominant disorders and reported in BOFS. NCBI

8. Autosomal dominant inheritance from an affected parent
   One affected parent can pass the changed gene to a child with a 50% chance in each pregnancy. NCBI

9. Parental germline mosaicism
   A parent can carry the change in some egg or sperm cells but look unaffected; recurrence can still happen. (Recognized in many single-gene dominant disorders and considered in BOFS counseling.) NCBI

10. Variant-specific activity differences
    Different TFAP2A variants can act as null, hypomorphic, or antimorphic (dominant-negative), which explains variable severity. OUP Academic

11. Disrupted retinoic-acid–responsive pathways
    TFAP2A responds to retinoic acid and helps eye morphogenesis; pathway disturbance helps explain eye findings. Frontiers

12. Impaired optic fissure closure programming
    TFAP2A helps with optic fissure closure; disruption can cause ocular coloboma. Frontiers

13. Abnormal branchial arch development
    Because TFAP2A directs face/neck development, its loss leads to thin/hemangiomatous skin and cervical defects. NCBI

14. Ectodermal tissue patterning defects
    Teeth, hair, and skin arise from ectoderm; TFAP2A problems can cause dental anomalies, hair changes, and skin pits. NCBI

15. Lacrimal drainage development defects
    TFAP2A dysfunction is linked to nasolacrimal duct stenosis or atresia. NCBI

16. Cranial nerve VII (facial nerve) development effects
    Partial facial nerve weakness (“asymmetric crying face”) can occur when cranial nerve development is affected. NCBI

17. Middle/inner ear structure anomalies
    Malformed ossicles or inner ear structures can lead to conductive or sensorineural hearing loss. NCBI

18. Renal morphogenesis disturbance
    A portion of patients have kidney malformations; TFAP2A changes likely affect kidney development programs. Nature

19. Gene–gene modifier effects
    Other genes may modify how severe BOFS looks in one family compared with another; this helps explain wide variation. (Modifier effects are a common explanation in single-gene syndromes and are discussed in TFAP2A research.) OUP Academic

20. Stochastic developmental variation
    Even with the same variant, random differences in early development can change severity between individuals. (This concept is widely recognized in developmental genetics and helps explain intrafamilial variability reported in BOFS.) NCBI

Symptoms and signs

Not every person has all of these. Features vary a lot, even within the same family.

1. Cervical or peri-auricular skin defects
   Thin skin, red “hemangiomatous” patches, or weeping erosions on the neck or near the ears are very common clues to BOFS. NCBI

2. Branchial cleft sinus or pits
   Small openings or sinus tracts can occur in the neck area from abnormal branchial arch development. NCBI

3. Ocular coloboma
   A missing piece in the iris, retina, or optic nerve forms because a fetal gap (optic fissure) does not close. This can lower vision. NCBI

4. Microphthalmia or anophthalmia
   One or both eyes may be small or absent, with major effects on vision and appearance. NCBI

5. Cataract
   Cloudy lens reduces clear vision. Cataracts can be present at birth or appear early. NCBI

6. Nasolacrimal duct stenosis or atresia
   Blocked tear drainage causes tearing, discharge, and recurrent eye infections unless treated. NCBI

7. Cleft lip or “pseudocleft” lip
   Some children have a real cleft lip. Others have deep philtral pillars that look like a repaired cleft (“pseudocleft”). Cleft palate may also be present. NCBI

8. Facial differences
   Common facial traits include wide-set eyes (hypertelorism/telecanthus), an up-slanted eye opening, and a broad nasal tip. NCBI

9. Upper-lip pits
   Small pits or openings on the upper lip are a helpful clinical clue. PMC

10. Facial nerve weakness
    A baby may show an asymmetric smile or “asymmetric crying face,” due to partial weakness of cranial nerve VII. NCBI

11. Ear malformations and hearing loss
    Outer or middle ear differences can cause conductive hearing loss. Sensorineural loss is less common but reported. NCBI

12. Dental anomalies
    Missing teeth (hypodontia), small or peg-shaped teeth, or enamel defects can occur. disorders.eyes.arizona.edu

13. Scalp cysts or skin lesions
    Subcutaneous scalp cysts and other skin findings are described in BOFS. disorders.eyes.arizona.edu

14. Kidney anomalies
    Some people have a single kidney, small kidneys, or other structural kidney differences, so screening is important. Nature

15. Feeding, growth, or airway issues in infancy
    Cleft palate and facial structure can lead to feeding difficulty or breathing concerns; growth may be slower in some children. NCBI

Diagnostic tests

Doctors usually begin with a careful exam, then add targeted tests of hearing, vision, kidneys, and genetics. The definitive test is genetic testing of TFAP2A. NCBI

A) Physical examination

1. Full craniofacial exam
   A clinician looks for cleft/pseudocleft lip, telecanthus, broad nasal tip, upper-lip pits, ear shape, and neck skin defects. This pattern points strongly toward BOFS. NCBI

2. Skin inspection of the neck and peri-auricular areas
   Finding thin, red, or weeping patches near the ears/neck supports BOFS versus other craniofacial syndromes. NCBI

3. Ophthalmic external inspection
   Doctors check eye size and shape for microphthalmia, look for iris coloboma, and note tearing or discharge that suggests blocked tear ducts. NCBI

4. Otoscopy and basic hearing screen
   Ear canal and eardrum are examined. Newborn or clinic hearing screens flag children who need full audiology. NCBI

5. Oral/dental exam
   Dentists or craniofacial teams document missing or peg-shaped teeth, palate shape, and enamel issues to guide care. disorders.eyes.arizona.edu

B) “Manual” bedside/clinical assessments

6. Cranial nerve exam (focus on facial nerve)
   A clinician checks facial movements and symmetry to detect subtle weakness. This helps with diagnosis and therapy planning. NCBI

7. Feeding and swallow assessment
   Speech-language or feeding therapists assess latch, suck, and swallow, especially with cleft palate, to prevent aspiration and poor growth. NCBI

8. Tear patency checks
   Simple office tests (e.g., fluorescein dye disappearance) suggest nasolacrimal obstruction and need for eye-care referral. NCBI

9. Developmental screening
   Standardized questionnaires and observation look for delays due to vision, hearing, or feeding issues, guiding early therapies. National Organization for Rare Disorders

10. Airway evaluation at bedside
    Clinical observation for stridor, mouth breathing, or sleep-disordered breathing helps triage ENT support in infants with clefting. NCBI

C) Laboratory and pathological tests

11. Molecular genetic testing of TFAP2A (sequencing)
    Next-generation sequencing identifies single-letter changes and small insertions/deletions in TFAP2A. This confirms the diagnosis when clinical signs suggest BOFS. orpha.net+1

12. Deletion/duplication analysis of TFAP2A
    If sequencing is negative, MLPA or copy-number testing searches for partial/whole-gene loss or gain. NCBI

13. Chromosomal microarray (CMA)
    CMA looks for larger missing or extra pieces that include TFAP2A or its regulatory regions, which can also cause BOFS features. NCBI

14. Targeted familial testing
    When a causative variant is known in the family, testing parents/siblings clarifies inheritance and recurrence risk. NCBI

15. Basic kidney function labs
    Blood creatinine, BUN, and urinalysis help detect kidney involvement found in a subset of patients. Nature

D) Electrodiagnostic tests

16. Auditory brainstem response (ABR)
    Objective hearing test for infants and young children. It detects conductive and sensorineural loss often linked to ear anomalies. NCBI

17. Electroretinography (ERG)
    Measures electrical activity of the retina. Helpful when structural eye defects exist and vision seems reduced. NCBI

18. Electro-oculography (EOG)
    Evaluates retinal pigment epithelium and eye movement function; can aid complex ocular phenotypes seen in TFAP2A disorders. Frontiers

E) Imaging and instrumented eye/ear/kidney tests

19. Comprehensive ophthalmologic exam with slit-lamp and dilated fundus exam
    Identifies coloboma, cataract, microphthalmia, and other anomalies; guides treatment planning. NCBI

20. Ocular imaging (OCT or ultrasound as age-appropriate)
    OCT (optical coherence tomography) or ocular ultrasound documents retinal structure when media are cloudy or eyes are small. NCBI

21. Dacryocystography or probing for tear-duct obstruction
    Imaging or procedural assessment confirms nasolacrimal stenosis/atresia and supports treatment decisions. NCBI

22. High-resolution temporal-bone CT (ear imaging)
    Shows ossicle or canal malformations in children with hearing loss to plan hearing rehabilitation. NCBI

23. Renal ultrasound
    Screens for kidney malformations in all individuals with BOFS because renal anomalies are not rare. Nature

24. 3D craniofacial imaging (when needed)
    CT or MRI can map complex clefts or airway concerns to help surgeons and the craniofacial team. NCBI

25. Prenatal imaging (targeted ultrasound/MRI if family variant known)
    If a pregnancy is at known risk, detailed imaging may detect major facial or eye anomalies; definitive prenatal diagnosis requires genetic testing. NCBI

Non-pharmacological treatments (therapies & other supports)

1. Genetic counseling and family planning
   Explains inheritance, recurrence risk, and options such as prenatal testing or preimplantation genetic testing. It helps families understand TFAP2A-related disease and plan future pregnancies in an informed way. Mechanism: education + risk assessment reduce uncertainty and enable timely screening of at-risk relatives. NCBI+1

2. Early cleft care pathway (team-based)
   Coordinated craniofacial team supports feeding, speech, dental alignment, and staged surgery (lip/palate repair when indicated). Mechanism: restore oral continuity and velopharyngeal function, improving growth, speech, and airway protection. NCBI

3. Speech-language therapy
   Targets articulation, resonance (hypernasality after cleft), and language development. Mechanism: structured motor-speech exercises and resonance strategies improve intelligibility and communication. NCBI

4. Feeding therapy (infant feeding support)
   Special bottles/techniques reduce nasal regurgitation and fatigue in infants with cleft or poor lip seal. Mechanism: biomechanical positioning and nipple flow control improve caloric intake and weight gain. NCBI

5. Airway & sleep strategies
   Positioning, humidification, and (when needed) CPAP/NIV for airway crowding or post-operative swelling. Mechanism: stabilizes upper airway patency and gas exchange while definitive repair is planned. NCBI

6. Wound and skin-defect care
   Moisture-balanced dressings, gentle cleansing, and infection surveillance for “weeping” branchial lesions; definitive treatment is excision when appropriate. Mechanism: reduces maceration and secondary infection as the child grows toward surgical candidacy. NCBI+1

7. Hearing assessment & amplification
   Newborn hearing screen → targeted audiology; consider hearing aids or bone-conduction devices if conductive loss occurs with branchial/ear malformations. Mechanism: restores auditory input during critical language windows. NCBI

8. Low-vision rehabilitation & protective eyewear
   For microphthalmia/coloboma, provide optical correction, magnifiers, orientation/mobility training, and UV-blocking eyewear. Mechanism: optimize residual vision and prevent further ocular surface damage. NCBI

9. Lacrimal hygiene & warm compresses
   If tear duct (nasolacrimal) stenosis causes tearing/infection, daily lid hygiene and massage may reduce stasis until ophthalmology intervenes. Mechanism: improves drainage and biofilm control. NCBI

10. Photoprotection (skin & eyes)
    Broad-spectrum sunscreen and sunglasses help protect fragile skin patches and photosensitive eyes. Mechanism: reduces UV-related irritation and scarring risks. NCBI

11. Occupational & physical therapy
    Focus on fine-motor/oral-motor coordination, posture, and endurance—especially after surgeries. Mechanism: neurodevelopmental practice enhances function and participation in school and play. NCBI

12. Orthodontic & dental care
    Early dental surveillance and staged orthodontics help maxillary arch form and occlusion after cleft repair. Mechanism: controlled tooth movement and hygiene reduce caries and malocclusion complications. NCBI

13. Psychosocial support & family counseling
    Addresses body-image concerns, procedure anxiety, and caregiver stress with age-appropriate counseling. Mechanism: coping-skills training improves adherence and quality of life. NCBI

14. Educational accommodations
    Individualized education plans for vision/hearing/speech challenges (preferential seating, assistive tech). Mechanism: reduces academic barriers and supports communication access. NCBI

15. Scar care after surgery
    Silicone gel/sheets and massage once incisions heal help flatten hypertrophic scars on the neck or lip. Mechanism: optimized collagen remodeling improves cosmesis and comfort. NCBI

16. Infection-prevention habits
    Hand hygiene, prompt care of otitis/skin infections, and up-to-date routine immunizations (per national schedules) reduce complications around surgeries and fragile skin sites. Mechanism: lowers pathogen load and peri-operative risk. NCBI

17. Renal/urinary monitoring
    Because some BOFS patients have urinary tract or kidney anomalies, periodic ultrasound/urinalysis can be considered per specialist advice. Mechanism: early detection of vesicoureteral reflux or scarring guides timely referral. NCBI

18. Sun- and wind-avoidance for ocular surface
    Hat, wraparound glasses, humidification, and blink breaks for surface symptoms. Mechanism: minimizes evaporation and mechanical irritation of compromised corneas. NCBI

19. Regular ophthalmology follow-up
    Surveillance for amblyopia, glaucoma risk, or exposure keratopathy; timing individualized. Mechanism: early detection prevents avoidable vision loss. NCBI

20. Care coordination (case management)
    Single point of contact aligns ENT, ophthalmology, craniofacial, dental, audiology, genetics, and therapy schedules. Mechanism: reduces missed care and improves outcomes across systems. NCBI

---

Drug treatments

Important: No drug treats the genetic cause of BOFS. Medicines below are commonly used for associated issues (ocular surface disease, infections, otitis, glaucoma risk, nasal inflammation, wound care, reflux/constipation around surgery, etc.). Doses are typical FDA-label examples for the indication named on the label; actual dosing must be individualized by a clinician.

1. Timolol ophthalmic 0.25–0.5% (β-blocker)
   Purpose: Reduce elevated intraocular pressure (e.g., in glaucoma risk scenarios). Mechanism: Lowers aqueous humor production via ciliary body β-receptor blockade. Typical dosing: 1 drop affected eye(s) once or twice daily per label variant; e.g., 1 drop once daily AM for Istalol 0.5%. Side effects: Local irritation; systemic β-blockade (bradycardia, bronchospasm) — avoid in asthma/COPD. Label source: FDA. FDA Access Data+1

2. Acetazolamide (systemic carbonic anhydrase inhibitor)
   Purpose: Short-term adjunct if significant intraocular pressure elevation or peri-operative need. Mechanism: Inhibits carbonic anhydrase, decreasing aqueous humor production. Typical dosing: Tablets 250 mg 1–4 times/day or ER 500 mg; dosing intervals/“rest days” per label and indication. Side effects: Paresthesias, GI upset, metabolic acidosis; sulfonamide cross-reactivity caution. Label source: DIAMOX. FDA Access Data+2FDA Access Data+2

3. Ofloxacin ophthalmic 0.3% (topical fluoroquinolone)
   Purpose: Bacterial conjunctivitis/corneal infection risk around ocular surface defects. Mechanism: Inhibits DNA gyrase/topoisomerase IV. Typical dosing: Per label for bacterial conjunctivitis. Side effects: Eye irritation; hypersensitivity. Label source: OCUFLOX. FDA Access Data

4. Ofloxacin otic 0.3% (ear drops)
   Purpose: Acute otitis externa/otorrhea in patients with branchial/ear anomalies. Mechanism: Fluoroquinolone bactericidal activity. Typical dosing: As per labeled otic indications. Side effects: Local irritation, taste disturbance. Label source: FLOXIN Otic. FDA Access Data+1

5. Polymyxin B/Trimethoprim ophthalmic (combination antibiotic)
   Purpose: Mild-to-moderate bacterial conjunctivitis/blepharoconjunctivitis. Mechanism: Polymyxin B disrupts bacterial membranes; trimethoprim blocks folate pathway. Typical dosing: 1 drop every 3 hours (max 6 doses/day) for 7–10 days (per labeling). Side effects: Local irritation; hypersensitivity. Source: FDA/DailyMed labeling. DailyMed

6. Topical ophthalmic corticosteroid/antibiotic combos (e.g., neomycin/polymyxin B/dexamethasone)
   Purpose: Short courses for significant ocular surface inflammation when indicated by an ophthalmologist. Mechanism: Anti-inflammatory steroid + antibacterial coverage. Risks: Steroids can raise IOP or worsen herpes keratitis—ophthalmology supervision essential. Source: FDA label example (MAXITROL). FDA Access Data

7. Fluticasone nasal spray (intranasal corticosteroid)
   Purpose: Allergic rhinitis/nasal inflammation that worsens mouth breathing/airway dryness around cleft repair. Mechanism: Local anti-inflammatory glucocorticoid action. Typical dosing: Once daily per label. Side effects: Epistaxis, nasal irritation. Label source: FLONASE. FDA Access Data+1

8. Silver sulfadiazine 1% cream (topical antimicrobial for complex wounds, specialist-directed)
   Purpose: For at-risk, deep, or surgically managed skin defects per burn/wound protocols. Mechanism: Broad antimicrobial action on wound surface. Cautions: Avoid in late pregnancy, premature infants, and G6PD deficiency; specialist use only. Label source: SILVADENE. FDA Access Data+1

9. Antibiotics for acute skin/ear infections (per culture & local guidelines)
   Purpose: Treat secondary infection in branchial lesions/otitis. Mechanism: Pathogen-specific. Examples: Fluoroquinolone otic as above; systemic agents individualized by organism and age. Source: ENT management references emphasize treating infection first, then definitive surgery. childrenshospital.org+1

10. Lubricating eye drops/ointments (OTC medical devices, not drugs)
    Purpose: Improve comfort and epithelial health in exposure/tear-film instability. Mechanism: Tear supplementation and evaporation control. Note: Labeled as devices rather than drugs; include here because they’re first-line ocular care. Source: Ophthalmic care principles in BOFS. NCBI

11. Analgesics (acetaminophen/ibuprofen—age-appropriate)
    Purpose: Peri-operative and wound pain control to maintain feeding, sleep, and participation in therapy. Mechanism: Central COX inhibition (acetaminophen) and peripheral COX inhibition (ibuprofen). Cautions: Dose by weight; avoid NSAIDs when contraindicated. Source: General pediatric surgical care; BOFS-specific surgery pathways. NCBI

12. Proton-pump inhibitor (e.g., omeprazole) for reflux when it jeopardizes wound healing
    Purpose: Protects surgical sites if severe reflux threatens repair integrity. Mechanism: Blocks gastric acid secretion. Cautions: Use shortest effective course, reassess need. Label source: FDA PPIs (representative). NCBI

13. Stool softener/osmotic laxative (polyethylene glycol)
    Purpose: Prevent straining or constipation after facial/neck surgery. Mechanism: Osmotic water retention in stool. Cautions: Dose-titrate to effect. Source: Peri-operative bowel regimens; PEG labels. NCBI

14. Topical nasal saline
    Purpose: Gentle nasal hygiene post-repair to reduce crusting and improve comfort. Mechanism: Isotonic cleansing; facilitates mucociliary function. Source: Post-cleft care practices. NCBI

15. Antihistamine eye drops (if allergic conjunctivitis coexists)
    Purpose: Reduce itch/rub that aggravates fragile ocular surfaces. Mechanism: H1-blockade/mast-cell stabilization depending on product. Caution: Choose preservative-friendly options for compromised corneas. Source: Ophthalmology guidance for surface disease. NCBI

16. Combination dorzolamide/timolol ophthalmic (if glaucoma treatment intensification needed)
    Purpose: Dual mechanism IOP reduction when monotherapy insufficient. Mechanism: CAI + β-blocker. Label source: COSOPT. FDA Access Data

17. Erythromycin ophthalmic ointment (nighttime lubrication + antibacterial prophylaxis)
    Purpose: Surface protection and bacterial prophylaxis in exposure risk. Mechanism: Macrolide antibacterial + ointment vehicle. Note: Use ophthalmic formulation (not dermatologic). Source: FDA labeling (class examples). FDA Access Data+1

18. Topical antibiotic skin agents (short course)
    Purpose: Secondary infection at superficial neck erosions as guided by clinician. Mechanism: Reduce bacterial load locally. Caution: Avoid prolonged use; monitor for contact dermatitis. Source: Wound/ENT guidance. NCBI

19. Peri-operative systemic antibiotics (case-by-case)
    Purpose: Standard surgical prophylaxis for branchial cleft excision or cleft repair per institutional protocols. Mechanism: Reduce surgical site infection risk. Source: ENT/craniofacial protocols. emedicine.medscape.com

20. Allergy/asthma medications if comorbid
    Purpose: Optimize airway health around surgeries. Mechanism: Indication-specific (e.g., inhaled steroids, leukotriene antagonists). Caution: Individualize to diagnosis. Source: Pediatric airway care principles. NCBI

Why I did not list “stem-cell” or “regenerative” drugs for BOFS: No FDA-approved stem-cell, gene, or “immunity-booster” drugs exist for BOFS. Using such products outside clinical trials is not recommended. Care is supportive and surgical. NCBI

---

Dietary molecular supplements

1. Omega-3 fatty acids (EPA/DHA)
   May help ocular surface comfort in dry-eye-like symptoms; evidence is mixed but some meta-analyses show symptom improvement with higher-dose, longer-duration EPA-rich formulas. Dose often 1–2 g/day EPA+DHA, individualized. Mechanism: anti-inflammatory lipid mediators that can stabilize tear film. Cochrane+2onlinelibrary.wiley.com+2

2. Vitamin A (avoid excess)
   Vitamin A is essential for ocular surface/epithelial health; deficiency is rare in high-income settings, and excess is harmful. Supplement only if a clinician documents deficiency; otherwise use dietary sources. Mechanism: supports epithelial differentiation/tear proteins. Office of Dietary Supplements

3. Vitamin D
   Supports immune and bone health; supplement if deficient per blood test (commonly 600–1,000 IU/day in children, 1,000–2,000 IU/day in adults, individualized by clinician). Mechanism: immunomodulatory effects and calcium homeostasis. Office of Dietary Supplements

4. Zinc (deficiency-targeted)
   Zinc is important for epithelial repair and immune function; consider only if dietary intake is low or lab deficiency is proven. Mechanism: cofactor for enzymes in wound healing and immunity. nutrition.bmj.com

5. Lutein/zeaxanthin (dietary carotenoids)
   Support retinal antioxidant capacity; while evidence is strongest in AMD, a carotenoid-rich diet (leafy greens, colorful vegetables) is a safe general approach. Mechanism: macular pigment antioxidants. Office of Dietary Supplements

6. Probiotics (general GI support when on antibiotics)
   May reduce antibiotic-associated diarrhea; choose pediatric-appropriate strains if advised. Mechanism: microbiome modulation. NCBI

7. Omega-3–rich diet (fish, flax, walnuts)
   Food-first strategy to reach supportive intakes without high-dose supplements. Mechanism: anti-inflammatory lipid profile. Office of Dietary Supplements

8. Adequate protein
   Supports surgical recovery and wound remodeling (eggs, dairy, legumes, fish). Mechanism: substrate for collagen and immune proteins. NCBI

9. Hydration & humidification
   While not a supplement, steady fluids and humid air improve mucosal moisture for ocular/nasal comfort. Mechanism: reduces evaporative loss. NCBI

10. Multivitamin only if diet is very limited
    Use age-appropriate doses; avoid megadosing fat-soluble vitamins. Mechanism: corrects broad insufficiencies. Office of Dietary Supplements

---

Immunity-booster / regenerative / stem-cell drugs

No such drugs are approved for BOFS. Current best practice is routine immunizations, good nutrition, and infection prevention; any “stem cell” or “regenerative” drug claims for BOFS should be regarded as unproven and avoided outside a clinical trial. Mechanism: n/a—not indicated. NCBI

---

Surgeries (what they are and why they’re done)

1. Excision of branchial cleft cyst/sinus/fistula
   Procedure: Definitive surgical removal of the entire tract through careful “stepladder”/stairstep incisions; delay if acutely infected until infection is treated. Why: Prevent recurrent infection, discharge, and skin breakdown; provide durable cure. emedicine.medscape.com+2optecoto.com+2

2. Cleft lip repair (cheiloplasty) and cleft palate repair (palatoplasty)
   Procedure: Staged reconstruction of lip and palate with muscle re-approximation. Why: Restores feeding, speech, and orofacial function; improves dental and airway outcomes over time. NCBI

3. Ocular surface/eyelid procedures (e.g., entropion/ptosis repair, tarsorrhaphy when needed)
   Procedure: Reposition lids or partially close the palpebral fissure to protect cornea; coloboma-related reconstructions are tailored. Why: Prevent exposure keratopathy and preserve vision. NCBI

4. Nasolacrimal duct probing/intubation or dacryocystorhinostomy
   Procedure: Relieve tear-duct obstruction that causes recurrent infections/tearing. Why: Improve drainage and comfort, reduce infection risk. NCBI

5. Secondary craniofacial/orthognathic/dental surgeries
   Procedure: Alveolar bone grafting, orthognathic alignment, or lip/nasal revisions during growth. Why: Optimize occlusion, speech resonance, and facial balance. NCBI

---

Preventions

1. Primary prevention is not possible because BOFS is genetic; focus on genetic counseling for family planning. NCBI

2. Treat infections early in neck skin or ears to prevent complications and surgical delays. childrenshospital.org

3. Sun/UV and wind protection for fragile skin and ocular surface. NCBI

4. Protect the cornea (lubricants, nighttime ointment, protective eyewear) when exposure risk exists. NCBI

5. Keep immunizations current to reduce peri-operative infectious risk. NCBI

6. Safe wound/skin care routines to reduce maceration and infection. NCBI

7. Regular eye and hearing checks to catch treatable problems early. NCBI

8. Dental hygiene and fluoride to protect enamel around cleft repairs. NCBI

9. Avoid unnecessary eye rubbing and dusty/smoky environments that irritate the ocular surface. NCBI

10. Coordinate care before travel/surgery (meds, supplies, letters). NCBI

---

When to see a doctor (or seek urgent care)

See your team promptly for: persistent eye pain/redness, light sensitivity, sudden vision changes, non-healing neck lesions, fever with neck swelling, foul ear discharge, breathing/swallowing difficulty, poor feeding/weight gain, or any post-operative bleeding or wound separation. Mechanism: these may signal infection, corneal injury, airway compromise, or surgical complications that benefit from early intervention. NCBI

---

What to eat and what to avoid

1. Protein-rich foods (eggs, dairy, legumes, fish) to support wound healing after surgeries. Avoid ultra-processed, low-protein diets. NCBI

2. Omega-3–rich options (fatty fish, walnuts, flax) for general anti-inflammatory support. Avoid high-sodium, dehydrating snacks right after ENT/cleft surgery. Office of Dietary Supplements

3. Soft foods post-oral surgery (purees, yogurt), advancing as advised. Avoid hard/crumbly foods that traumatize repairs. NCBI

4. Hydration & humid air for mucosal comfort. Avoid caffeinated dehydration during recovery. NCBI

5. Colorful vegetables/leafy greens (carotenoids) for ocular health. Avoid vitamin A megadoses without medical advice. Office of Dietary Supplements

6. Calcium + vitamin D through diet (and supplements only if deficient). Avoid unmonitored high-dose vitamin D. Office of Dietary Supplements

7. Iron- and zinc-containing foods (meats, legumes, seeds) for healing; supplement only if deficient. Avoid excess zinc (> UL) which can cause copper deficiency. nutrition.bmj.com

8. Probiotic-containing foods (yogurt/kefir) during antibiotic courses, if tolerated. Avoid unpasteurized products in young children. NCBI

9. Limit irritants (spicy/acidic foods) soon after palatal surgery to reduce discomfort. Avoid hot-temperature foods that can burn healing tissue. NCBI

10. Balanced, fiber-adequate meals to prevent constipation with peri-operative pain meds. Avoid low-fiber patterns that worsen straining. NCBI

---

FAQs

1. Is BOFS inherited?
   Usually autosomal dominant; a single TFAP2A variant can cause BOFS. Some cases are new (de novo). Genetic counseling is recommended. NCBI+1

2. Can BOFS be cured with medicine?
   No. Care is supportive and surgical, tailored to each organ system affected. NCBI

3. Will my child need surgery?
   Often yes—commonly branchial tract excision and cleft repairs; timing depends on growth, infection status, and team planning. emedicine.medscape.com+1

4. Are the eye problems treatable?
   Some are protectable/manageable (lubricants, eyelid procedures, low-vision aids), while others (e.g., microphthalmia/anophthalmia) may limit vision—regular ophthalmology is key. NCBI

5. What about blocked tear ducts?
   Warm compresses/lid care first; persistent obstruction may need probing or surgery. NCBI

6. Is hearing always affected?
   Not always; because ear structures can be atypical, routine audiology is wise. Amplification is used if hearing loss is found. NCBI

7. Do vaccines change because of BOFS?
   No special schedule is required; follow national schedules unless your clinician advises otherwise. NCBI

8. Are stem cells or gene therapy available for BOFS?
   No approved therapies yet; avoid unproven “regenerative” treatments outside clinical trials. NCBI

9. Could kidneys be involved?
   Some individuals have urinary tract anomalies; screening is individualized by nephrology/urology. NCBI

10. Will my child grow normally?
    Growth can be affected by feeding difficulties and surgeries; with team support, many children achieve good growth trajectories. NCBI

11. Is BOFS the same as branchio-oto-renal (BOR) syndrome?
    No—distinct syndromes; BOR typically features ear/hearing and kidney anomalies without the BOFS facial/skin pattern. Genetics teams help distinguish them. NCBI

12. What’s the long-term outlook?
    With early, coordinated care, many issues are manageable, and quality of life can be good. Vision varies by eye anomalies. NCBI

13. Can we prevent BOFS in future pregnancies?
    If the familial TFAP2A variant is known, prenatal or preimplantation testing may be options. NCBI

14. Does BOFS affect intelligence?
    Neurodevelopment is variable; most concerns relate to hearing/vision/speech access rather than primary cognitive deficits—early therapies help. NCBI

15. Where can we learn more?
    High-quality overviews: GeneReviews, MedlinePlus Genetics, Orphanet, GARD/NORD. National Organization for Rare Disorders+4NCBI+4MedlinePlus+4

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 02, 2025.